Wael M. ElShamy

San Diego Biomedical Research Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.7kcitations65works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(15), Nerve injury and regeneration(9), Cancer-related Molecular Pathways(9), Animal Virus Infections Studies(8), Virus-based gene therapy research(7)

Publications65 total

MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
Viruses·2023· 6 citedOpen Access
MRP8/14 is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets that Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
Preprints.org·2023· 2 citedOpen Access
Supplementary Data from The Immunosuppressive Microenvironment in BRCA1-IRIS–Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages
2023Open Access
Data from The Immunosuppressive Microenvironment in BRCA1-IRIS–Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages
2023Open Access
Supplementary Data from The Immunosuppressive Microenvironment in BRCA1-IRIS–Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages
2023Open Access
Data from The Immunosuppressive Microenvironment in BRCA1-IRIS–Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages
2023Open Access
Supplementary Figure 2 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Table 1 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Data from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Figure Legends 1-2 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Figure 2 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Figure Legends 1-2 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Table 1 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Data from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Figure 1 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Supplementary Figure 1 from BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
2023Open Access
Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding.
PubMed·2022· 4 citedOpen Access
The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs
Cancer Gene Therapy·2021· 14 cited
The Immunosuppressive Microenvironment in BRCA1-IRIS–Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages
Cancer Research·2020· 88 citedOpen Access
Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis
Scientific Reports·2019· 36 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Yoshiko Shimizu(9), Patrik Ernfors(8), Bibbin T. Paul(6), Zannel Blanchard(6), Jim Koziol(5), Abhilasha Sinha(5), David M. Livingston(4), Kerri L. Chock(4), Jamie M.S. Allison(4), Daniel Ryan(4), Nicole Mullins(4), Brenda Y. Hernandez(4), Danielle Bogan(4), Lauren H. Gardner(3), Hugh Luk(3), David Horio(3), Jeffrey Killeen(3), Miguel Ángel Pujana(2), Eman Sami(2), James A. Koziol(2)